1-3 of 3
Andrew D Norden, MD MPH MBA
Close
Sort by
Journal Articles

Chromosome 1q Amplification Is Associated with a History of Prior Malignancies Among Patients Newly Diagnosed with Multiple Myeloma

Elizabeth B Lamont, MD MS, MMSc, Andrew J. Yee, MD, Stuart L. Goldberg, MD, Andrew D Norden, MD MPH, MBA
Journal: Blood
Blood (2019) 134 (Supplement_1): 2193.
https://doi.org/10.1182/blood-2019-125407
Published: 2019
Journal Articles

Multiple Myeloma Staging in Real World Clinical Practice Is Suboptimal: Absence of Beta-2-Microglobulin and Serum Lactase Dehydrogenase Testing Are Limiting Factors

Noa Biran, MD, Sukhmani Gill, MD, Andrew D Norden, MD MPH MBA, David H. Vesole, MD PhD, Wallace G Stephen, MD, Kenneth D Nahum, DO, David S Siegel, MD PhD, Stuart L. Goldberg, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5587.
https://doi.org/10.1182/blood-2018-99-119559
Published: 2018
Journal Articles

FISH Abnormalities (including R-ISS defining and IgH mutations) Are Similar across Race and Ethnicity Among Patients with Multiple Myeloma (except higher rates of t(4:14) in Minorities and 1q Amplifications in Asian/Indians)

Noa Biran, MD, Camille Johnson, MD, Andrew D Norden, MD MPH MBA, Roger Kumar, BS MS, David H. Vesole, MD PhD, Seth H. Berk, MD, Denis B. Fitzgerald, MD, David S Siegel, MD PhD, Stuart L. Goldberg, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5608.
https://doi.org/10.1182/blood-2018-99-119744
Published: 2018